RU95106139A - Method of lung tuberculosis treatment
- Google Patents
Method of lung tuberculosis treatment
Info
Publication number
RU95106139A
RU95106139ARU95106139/14ARU95106139ARU95106139ARU 95106139 ARU95106139 ARU 95106139ARU 95106139/14 ARU95106139/14 ARU 95106139/14ARU 95106139 ARU95106139 ARU 95106139ARU 95106139 ARU95106139 ARU 95106139A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by И.И. БелянинfiledCriticalИ.И. Белянин
Priority to RU95106139ApriorityCriticalpatent/RU2121351C1/en
Publication of RU95106139ApublicationCriticalpatent/RU95106139A/en
Application grantedgrantedCritical
Publication of RU2121351C1publicationCriticalpatent/RU2121351C1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
FIELD: medicine, pulmonology. SUBSTANCE: method involves systemic intravenous administration of the dissolved ozone, once per a day, for 3-15 days at a single dose 0.1-0.7 mg ozone/1 kg patient body mass. EFFECT: enhanced effectiveness of treatment, accelerated treatment method.
Claims (1)
Предлагается способ лечения туберкулеза легких, отличающийся от известного тем, что пациентам дополнительно к традиционной противотуберкулезной терапии и патогенетическим средствам лечения дополнительно производят системное внутривенное введение растворенного озона 1 раз в 3 - 15 дней с разовой дозой 0,1 - 0,7 мг озона на 1 кг массы тела пациента. Системное введение растворенного озона позволяет ускорить сроки абациллирования больного, закрытия каверн и излечения туберкулеза легких, в том числе и у лиц, резистентных к проводимой химиотерапии.A method for the treatment of pulmonary tuberculosis is proposed, which differs from the known one in that, in addition to traditional anti-tuberculosis therapy and pathogenetic treatments, patients additionally receive systemic intravenous administration of dissolved ozone once every 3 to 15 days with a single dose of 0.1 to 0.7 mg of ozone per 1 kg body weight of the patient. Systemic administration of dissolved ozone allows to accelerate the time of patient's abacillation, closure of caverns and cure pulmonary tuberculosis, including in patients resistant to chemotherapy.
RU95106139A1995-04-181995-04-18Method for treating pulmonary tuberculosis
RU2121351C1
(en)